A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Clinical trial NCT05542264 · COMPLETED
Trial details
- NCT number
- NCT05542264
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2024-02-12
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.